Finlay Minerals Announces Increased Budget for PIL and ATTY Projects
Both projects are situated in the highly prospective Toodoggone District of British Columbia, which continues to develop as an important copper-gold (Cu-Au) district with significant potential for further discoveries.
Initially, the 2025 budget was set at a minimum of $750,000 for the PIL property and $500,000 for the ATTY property. However, these amounts have now been revised to up to $2.6 million for the PIL project and up to $1.0 million for the ATTY project. Both programs are fully funded under the Earn-In Agreements with Freeport. According to these agreements, Freeport may earn an 80% interest in each property by investing a total of $35 million in exploration expenditures and making cash payments totaling $4.1 million over/up to six years. 2 Until the Finlay-Freeport Earn-In Agreements complete, Finlay owns 100% of both properties.
The PIL Property lies in the heart of the Toodoggone region and features several porphyry copper-gold (Cu-Au) targets, along with associated epithermal gold-silver (Au-Ag) mineralization. To date, 18 porphyry Cu ± Mo ± Au and porphyry-related low- and high-sulphidation epithermal Au-Ag occurrences have been outlined on the PIL Property. The PIL property is adjacent to Amarc Resources and Freeport-McMoRan's JOY Project, as well as TDG Gold Corp.'s Shasta/Baker and Sofia Properties. It is also situated 25 kilometres ("km") northwest of Centerra Gold's former Kemess South Mine and 15 km east of Thesis Gold's Lawyers Project.
The ATTY Property covers 3,875 hectares of sub-alpine terrain in the southern Toodoggone region, an area known for significant porphyry copper-gold (Cu-Au) and epithermal gold-silver (Au-Ag) deposits. It is located between Centerra Gold's Kemess Project and the JOY Project, held by Amarc Resources and Freeport-McMoRan. The KEM target on the ATTY Property resembles the Kemess North Trend, which is home to the Kemess Underground and Kemess East deposits. Exploration will focus on the Wrich target, located near the copper geochemical anomaly at the SWT target on the JOY Property. This anomaly extends over 2 km and continues onto the ATTY Property for an additional 1.2 km to the southeast.
The 2025 programs at the PIL and ATTY are well underway with:
Detailed property-wide, 100 metre line-spaced airborne magnetic surveys completed on both properties;
Detailed geological and alteration mapping and expanded rock and soil sampling on up to 8 target areas on the PIL underway, with the ATTY expected to start by the end of July;
53 line-km of induced polarization ("IP") geophysical surveys planned on the PIL and 16 line-km on the ATTY, and
Finlay acting as the Operator on both properties.
Finlay's President and CEO, Ilona Lindsay, states:
"We are very pleased with the substantial increase in approved funding for both the PIL and the ATTY. This additional funding will allow us to identify and prioritize as many targets as possible for drilling in 2026."
References:
Freeport-McMoRan (FCX) is a leading international metals company focused on copper, with major operations in the Americas and Indonesia and significant reserves of copper, gold, and molybdenum.
Finlay news releases NR 03-25 dated April 17, 2025 entitled: " Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties" and NR 05-25 dated May 2, 2025 and entitled: " Finlay Minerals Receives TSX Venture Exchange Approval for PIL Earn-In Agreement."
Qualified Person:
Wade Barnes, P. Geo. and Vice President, Exploration for Finlay Minerals and a qualified person as defined by National Instrument 43-101, has approved the technical content of this news release.
About Finlay Minerals Ltd.
Finlay is a TSXV company focused on exploration for base and precious metal deposits with five properties in northern British Columbia:
Finlay trades under the symbol "FYL" on the TSXV and under the symbol "FYMNF" on the OTCQB. For further information and details, please visit the Company's website at www.finlayminerals.com.
On behalf of the Board of Directors,
Robert F. Brown,
Executive Chairman of the Board
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that address events or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as "expect", "plan", "anticipate", "project", "target", "potential", "schedule", "forecast", "budget", "estimate", "intend" or "believe" and similar expressions or their negative connotations, or that events or conditions "will", "would", "may", "could", "should" or "might" occur. All such forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Forward-looking statements in this news release include statements regarding, among others, the exploration plans for the PIL & ATTY Properties. Although Finlay believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploration successes, and continued availability of capital and financing and general economic, market or business conditions. These forward-looking statements are based on a number of assumptions including, among other things, assumptions regarding general business and economic conditions, the timing and receipt of regulatory and governmental approvals, the ability of Finlay and other parties to satisfy stock exchange and other regulatory requirements in a timely manner, the availability of financing for Finlay's proposed transactions and programs on reasonable terms, and the ability of third-party service providers to deliver services in a timely manner. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Finlay does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future or otherwise, except as required by applicable law.
SOURCE Finlay Minerals Ltd.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
6 hours ago
- Cision Canada
Dye & Durham Initiates Review of Strategic Alternatives
TORONTO, July 29, 2025 /CNW/ - Dye & Durham Limited ("Dye & Durham" or the "Company") (TSX: DND), a leading provider of cloud-based legal practice management software, today announced that its Board of Directors (the "Board") has initiated a review of strategic alternatives to maximize value for all shareholders. The review may include a sale of the Company, asset sales, recapitalizations or potential mergers. The Company does not intend to make any further public comment regarding the strategic review until it has been completed. In connection with this announcement, the Company has entered into a Cooperation Agreement ("Agreement") with Plantro Ltd. ("Plantro") under which Plantro has agreed to withdraw its special meeting requisition. As part of this agreement, David Danziger, CPA, CA will be appointed to the Board forthwith. Mr. Danziger will also join and serve as Chair of a newly formed Special Committee tasked with leading the strategic review. The Agreement also contains customary standstill provisions and voting commitments. "Over the past several weeks, the Board has engaged with shareholders to carefully consider Dye & Durham's next steps," said Board Chair Arnaud Ajdler. "We appreciate the constructive and pragmatic engagement that we have had with Plantro and Matt Proud toward our shared goal of enhancing value for the Company's shareholders, and we are pleased to have reached a resolution. We welcome David, whose M&A and accounting expertise and significant public company director experience will be incredibly additive." "As one of the Company's largest and longest-standing shareholders, we are pleased to have reached a constructive agreement with the Board that provides the basis to thoughtfully pursue a sale of the Company to preserve and maximize value for all shareholders," said Matt Proud, spokesperson for Plantro. "Plantro is appreciative of the efforts of the Board Chair Arnaud Ajdler in developing this collaborative framework. We look forward to remaining an engaged and constructive shareholder." David Danziger, CPA, CA Biography David Danziger, CPA, CA, is an experienced finance leader and corporate director with an extensive background in audit, accounting, M&A and management consulting. Previously, he was the Senior Vice President, Assurance, and the National Leader of Public Companies at MNP LLP, Canada's fifth-largest accounting firm. Mr. Danziger continues to serve as a Senior Advisor for MNP LLP working on special projects and supporting the Public Company Audit Team nationally. Mr. Danziger has served as a director for a range of technology, mining and life sciences companies listed on the TSX, TSXV, CSE and NYSE. About Dye & Durham Limited Dye & Durham Limited provides premier practice management solutions empowering legal professionals every day, delivers vital data insights to support critical corporate transactions and enables the essential payments infrastructure trusted by government and financial institutions. The company has operations in Canada, the United Kingdom, Ireland, Australia, and South Africa. Additional information can be found at Forward-Looking Statements This press release may contain forward-looking information within the meaning of applicable securities laws, which reflects Dye & Durham's current expectations regarding future events. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "appears", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In particular, statements regarding the review of strategic alternatives, and the potential sale of the Company, divestiture of assets, recapitalization or merger transactions, and the Company's efforts to maximize value for all shareholders are forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Dye & Durham's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the outcome of the strategic review process, the ability to successfully enter into a transaction with a third party relating to the Company, including a potential sale, divesture of assets, recapitalization or merger transaction, and the factors discussed under "Risk Factors" in Dye & Durham's most recent annual information form. Dye & Durham does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Cision Canada
8 hours ago
- Cision Canada
JIVA Technologies Announces Filing of Application for Management Cease Trade Order
VANCOUVER, BC , July 29, 2025 /CNW/ -- JIVA Technologies Inc. (CSE: JIVA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("JIVA" or the "Company") announces that it will miss its filing deadline of July 29, 2025 to file audited annual financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the financial year ended March 31, 2025 (collectively, the "Annual Filings"), as required under applicable Canadian securities laws. In connection with the Company's inability to file the Annual Filings on time, the Company has applied for a Management Cease Trade Order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203") and is waiting for the decision of the British Columbia Securities Commission (the "BCSC") with respect to its application. The Company is applying for a MCTO as a result of the Company having been advised by its auditor on July 28, 2025 that the auditor is unable to complete its audit of the Company by the required filing deadline. The Company expects to file the Annual Filings on or about September 29, 2025 , but in any event as soon as they are available. The Company will issue a news release once the Annual Filings have been filed. Until the Company files the Annual Filings, it will comply with the alternative information guidelines set out in NP 12-203. The guidelines, among other things, require the Company to issue bi-weekly default status reports, in the form of news releases, for so long as the Annual Filings have not been filed. During the MCTO, the general investing public will continue to be able to trade in the Company's common shares listed on the Canadian Securities Exchange. However, the Company's Chief Executive Officer, Chief Financial Officer, and such other directors, officers and persons as determined by the applicable regulatory authorities will not be able to trade in the Company's common shares, nor will the Company be able to, directly or indirectly, issue securities to or acquire securities from an insider or employee of the Company except in accordance with legally binding obligations to do so existing as of July 30, 2025 , being the date of the Company's anticipated continuous disclosure default. The Company is not subject to any insolvency proceedings. If the Company provides any information to any of its creditors during the period in which it is in default of filing the Annual Filings, the Company confirms that it will also file material change reports on SEDAR containing such information. About JIVA Technologies Inc. JIVA Technologies is dedicated to building niche online wellness communities and creating immersive physical environments. With a proven track record in e- commerce marketplaces, bolstered by expert UI/UX design and SEO, JIVA now focuses on joint ventures to support wellness brands in developing their online presence. The company owns and operates Bloombox Club, an online plant delivery marketplace serving the United States , Germany , the United Kingdom , Austria , the Republic of Ireland , France , Spain , and Italy , as well as The Locavore Bar and Grill, a vibrant dining and gathering destination in Squamish, BC . Recently, JIVA became a shareholder in VEG House, a leader in the plant-based space, through a share exchange agreement. Committed to e-commerce, marketing, and wellness, JIVA's mission is to cultivate online communities of like-minded consumers through education and collaboration. The company is actively pursuing joint ventures, such as the recently announced partnership with LIV3 for SugarShield, to empower wellness brands online by building their websites and managing all digital marketing. Contact Lorne Rapkin Chief Executive Officer (416) 419-1415 Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release. Cautionary Note Regarding Forward-Looking Statements This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "expects", "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, management's expectations that it will miss the filing deadline for the Annual Filings, the issuance by the BCSC of an MCTO, and the ability of the Company to file the Annual Filings within the time period described herein. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things: the BCSC may not issue an MCTO; the Company being unable file the Annual Filings in the proposed timeframe; recent market volatility; and the state of the financial markets for the Company's securities. In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the BCSC will issue an MCTO and the Company will be able to file the Annual Filings in the proposed time frame. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor. Logo - SOURCE JIVA Technologies Inc.
Cision Canada
8 hours ago
- Cision Canada
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
SASKATOON, SK, July 29, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed a first tranche (the " First Tranche") of its non-brokered private placement (the " Offering") of up to 1,408,450 units (each a "Unit") for up to CAD $1,000,000. Under the First Tranche of the Offering, 450,281 Units were issued at a price of $0.71 per Unit for gross proceeds of approximately $319,700. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of five consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued by way of the First Tranche are subject to a hold period expiring November 30, 2025, in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Private Placement. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Private Placement are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
